Cargando…
Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients
SIMPLE SUMMARY: Many different therapies are applied to fight tumor disease. Blood-based biosources, like circulating tumor cells (CTCs), offer the opportunity to monitor the healing progression and the real-time response to the therapy. In this review, we analyze the outcomes of the clinical trials...
Autores principales: | Theil, Gerit, Fornara, Paolo, Bialek, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765455/ https://www.ncbi.nlm.nih.gov/pubmed/33333999 http://dx.doi.org/10.3390/cancers12123782 |
Ejemplares similares
-
Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
por: Theil, Gerit, et al.
Publicado: (2021) -
Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer
por: Theil, Gerit, et al.
Publicado: (2022) -
In vivo isolation of circulating tumor cells in patients with different stages of prostate cancer
por: Theil, Gerit, et al.
Publicado: (2021) -
Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer
por: Bialek, Joanna, et al.
Publicado: (2021) -
Potential Use of CTCs as Biomarkers in Renal Cancer Patients
por: Bialek, Joanna, et al.
Publicado: (2022)